The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Pulmonary Outcome at 1 Year Corrected Age in Premature Infants Treated at Birth With Recombinant Human CuZn Superoxide Dismutase
Abstract
Objective. To examine whether treatment of premature infants with intratracheal recombinant human CuZn superoxide dismutase (r-h CuZnSOD) reduces bronchopulmonary dysplasia and improves pulmonary outcome at 1 year corrected age. Design. Three hundred two premature infants (600–1200 g birth weight) treated with exogenous surfactant at birth for respiratory distress syndrome were randomized to receive either intratracheal r-h CuZnSOD (5 mg/kg in 2 mL/kg saline) or placebo every 48 hours (as long as intubation was required) for up to 1 month of age. Short-term, as well as longer-term pulmonary outcome was assessed. Results. There were no differences between groups in the incidence of death or the development of bronchopulmonary dysplasia (oxygen requirement with an Edwards chest radiograph score of ≥3) at 28 days of life or 36 weeks’ postmenstrual age. r-h CuZnSOD was well-tolerated and not associated with significant increases in any adverse event. At a median of 1 year corrected age, health assessments and physical examinations were performed on 209 (80%) surviving infants, with complete data available on 189 infants. Thirty-seven percent of placebo-treated infants had repeated episodes of wheezing or other respiratory illness severe enough to require treatment with asthma medications such as bronchodilators and/or corticosteroids compared with 24% of r-h CuZnSOD-treated infants, a 36% reduction. In infants <27 weeks’ gestation, 42% treated with placebo received asthma medications compared with 19% of r-h CuZnSOD-treated infants, a 55% decrease. Infants <27 weeks’ gestation who received r-h CuZnSOD also had a 55% decrease in emergency department visits and a 44% decrease in subsequent hospitalizations. Growth measurements and the results of physical examinations were comparable between groups. Conclusions. These data indicate that treatment at birth with r-h CuZnSOD may reduce early pulmonary injury, resulting in improved clinical status when measured at 1 year corrected age. r-h CuZnSOD appears to be a safe and effective therapy that improves pulmonary outcome in high-risk premature infants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JOBE, A. H., & BANCALARI, E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2011060 · Cited by 4,795
Shennan, A. T., Dunn, M. S., Ohlsson, A., Lennox, K., & Hoskins, E. M. (1988) · Pediatrics · doi:10.1542/peds.82.4.527 · Cited by 1,254
The New BPD: An Arrest of Lung Development
Jobe, A. J. (1999) · Pediatric Research · doi:10.1203/00006450-199912000-00007 · Cited by 1,013
The STOP-ROP Multicenter Study Group (2000) · Pediatrics · doi:10.1542/peds.105.2.295 · Cited by 660
Flynn, J. T., & Bancalari, E. (2000) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1067/mpa.2000.105823 · Cited by 620
Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia.
Carlsson, L. M., Jonsson, J., Edlund, T., & Marklund, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6264 · Cited by 487
Turrens, J. F., Crapo, J. D., & Freeman, B. A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111210 · Cited by 480
Adverse Effects of Early Dexamethasone Treatment in Extremely-Low-Birth-Weight Infants
Stark, A. R., Carlo, W. A., Tyson, J. E., Papile, L.-A., Wright, L. L., Shankaran, S., Donovan, E. F., Oh, W., Bauer, C. R., Saha, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440203 · Cited by 479
Sohn, A. H., Garrett, D. O., Sinkowitz-Cochran, R. L., Grohskopf, L. A., Levine, G. L., Stover, B. H., Siegel, J. D., & Jarvis, W. R. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.119442 · Cited by 418
Murphy, B. P., Inder, T. E., Huppi, P. S., Warfield, S., Zientara, G. P., Kikinis, R., Jolesz, F. A., & Volpe, J. J. (2001) · Pediatrics · doi:10.1542/peds.107.2.217 · Cited by 369
Wispé, J. R., Warner, B. B., Clark, J. C., Dey, C. R., Neuman, J., Glasser, S. W., Crapo, J. D., Chang, L. Y., & Whitsett, J. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35927-1 · Cited by 314
Frank, L., & Groseclose, E. E. (1984) · Pediatric Research · doi:10.1203/00006450-198403000-00004 · Cited by 257
An Improper Use of Statistical Significance Testing in Studying Covariables
DALES, L. G., & URY, H. K. (1978) · International Journal of Epidemiology · doi:10.1093/ije/7.4.373 · Cited by 169
Frank, L., & Sosenko, I. R. S. (1991) · Pediatric Research · doi:10.1203/00006450-199103000-00014 · Cited by 167
Pitkänen, O. M., Hallman, M., & ANDERSSON, S. M. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82668-x · Cited by 166
Plasma 3-Nitrotyrosine Is Elevated in Premature Infants Who Develop Bronchopulmonary Dysplasia
Banks, B. A., Ischiropoulos, H., McClelland, M., Ballard, P. L., & Ballard, R. A. (1998) · PEDIATRICS · doi:10.1542/peds.101.5.870 · Cited by 142
White, C. W., Avraham, K. B., Shanley, P. F., & Groner, Y. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115249 · Cited by 137
Davis, J. M., Rosenfeld, W., Richter, S. E., Parad, R. B., Gewolb, I. H., Spitzer, A. R., Carlo, W. A., Couser, R. J., Price, A. P., Flaster, E. R., et al. (1997) · PEDIATRICS · doi:10.1542/peds.100.1.24 · Cited by 129
Self-citationAntioxidants as Therapy in the Newborn: Some Words of Caution
Jankov, R. P., Negus, A., & Tanswell, A. K. (2001) · Pediatric Research · doi:10.1203/00006450-200112000-00009 · Cited by 117
Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury
Davis, J. M., Rosenfeld, W., Sanders, R. J., & Gonenne, A. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.74.5.2234 · Cited by 101
Self-citationEarly protein oxidation in the neonatal lung is related to development of chronic lung disease
Varsila, E., Pesonen, E., & Andersson, S. (1995) · Acta Paediatrica · doi:10.1111/j.1651-2227.1995.tb13552.x · Cited by 88
Ilizarov, A. M., Koo, H.-C., Kazzaz, J. A., Mantell, L. L., Li, Y., Bhapat, R., Pollack, S. Z., Horowitz, S., & Davis, J. M. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.4.4240 · Cited by 64
Self-citation
Cited by
Bronchopulmonary Dysplasia: Executive Summary of a Workshop
Higgins, R. D., Jobe, A. H., Koso-Thomas, M., Bancalari, E., Viscardi, R. M., Hartert, T. V., Ryan, R. M., Kallapur, S. G., Steinhorn, R. H., Konduri, G. G., et al. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.01.043 · Cited by 956
Oxygen Toxicity and Reactive Oxygen Species: The Devil Is in the Details
Auten, R. L., & Davis, J. M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181a9eafb · Cited by 751
Self-citationOxidant and antioxidant balance in the airways and airway diseases
Rahman, I., Biswas, S. K., & Kode, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.087 · Cited by 727
Kinsella, J. P., Greenough, A., & Abman, S. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68615-7 · Cited by 454
Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes
Davidson, L., & Berkelhamer, S. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6010004 · Cited by 415
Metadata
- Authors
- Davis, J. M., Parad, R. B., Michele, T., Allred, E., Price, A., Rosenfeld, W., & for the North American Recombinant Human CuZnSOD Study Group
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2003-03-01
- Volume
- 111
- Issue
- 3
- Pages
- 469-476
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2094000643
- Cited by
- 268
- References
- 22
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.